LONDON (AP) — Prince Charles is praising Cambridge as a center of scientific collaboration as the pharmaceutical company AstraZeneca opened a 1 billion-pound ($1.34 billion) research center there on Tuesday. AstraZeneca hopes the facility will build on work in developing one of the first COVID-19 vaccines. The 19,000 square-meter (more than 200,000 square-foot) complex near the University of Cambridge will house more than 2,200 research scientists. It joins a cluster of businesses seeking to make Cambridge a hub for life sciences research similar to what California’s Silicon Valley is for the technology industry. AstraZeneca’s COVID-19 vaccine is widely used across the world and the company plans to ask the Food and Drug Administration to approve it for use in the United States.
AstraZeneca opens research center as UK builds science hub
